Stay updated on PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial page.

Latest updates to the PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedNew investigators and updated contact details were added, and the study locations were updated to 76. Several investigators were removed in the update.SummaryDifference0.4%

- Check9 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check17 days agoChange DetectedAdded a new NEJM publication citation to the Publications section for the rezatapopt Phase 1 study, listing authors including Dumbrava et al. and DOI 10.1056/NEJMoa2508820.SummaryDifference0.0%

- Check31 days agoChange DetectedAdded University of San Diego Moores Cancer Center in La Jolla, CA, with investigator Shumei Kato, MD, and noted the study status as Terminated/Withdrawn. Removed the Chicago, IL site (Robert H. Lurie Comprehensive Cancer Center) and investigators Devalingam Mahalingam, MD, PhD and John Kaczmar, MD, along with the contact Martin Sebastian, MD.SummaryDifference1%

- Check38 days agoChange DetectedMinor CMS revision from v3.4.0 to v3.4.1 with no observed impact on the study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page now includes UI options to show or hide the glossary and updates several administrative labels (Last Update Submitted that Met QC Criteria, Last Update Posted) and the revision number from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial page.